Societal Impact Of Extending Market Exclusivity For Conventional Drugs

被引：0
|
作者：
Musselwhite, Laura [1 ]
Collingsworth, Bryan [1 ]
机构：
[1] Univ Allied Essential Med, Berkeley, CA 94705 USA
来源：
HEALTH AFFAIRS | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1377/hlthaff.2011.0310
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ECONOMIC IMPACT OF THE END OF THE MARKET EXCLUSIVITY FOR ORPHAN DRUGS
    Kandel, M.
    Degrassat-Theas, A.
    de Curzon, Parent O.
    Sinegre, M.
    Paubel, P.
    VALUE IN HEALTH, 2015, 18 (07) : A678 - A678
  • [2] Market Exclusivity For Drugs: The Authors Reply
    Goldman, Dana P.
    Lakdawalla, Darius N.
    Philipson, Tomas J.
    HEALTH AFFAIRS, 2011, 30 (04)
  • [3] Extending the market exclusivity of therapeutic antibodies through dosage patents
    Storz, Ulrich
    MABS, 2016, 8 (05) : 841 - 847
  • [4] Determinants of Market Exclusivity for Prescription Drugs in the United States
    Kesselheim, Aaron S.
    Sinha, Michael S.
    Avorn, Jerry
    JAMA INTERNAL MEDICINE, 2017, 177 (11) : 1658 - 1664
  • [5] EU to review rare disease drugs market exclusivity
    Sheridan, C
    NATURE BIOTECHNOLOGY, 2004, 22 (09) : 1061 - 1061
  • [6] EU to review rare disease drugs market exclusivity
    Cormac Sheridan
    Nature Biotechnology, 2004, 22 : 1061 - 1061
  • [7] THE IMPACT OF OUT-OF-POCKET SPENDING ON THE PENETRATION OF GENERIC DRUGS AFTER THE EXPIRY OF THE MARKET EXCLUSIVITY
    Cioni, L.
    Tettamanti, A.
    Urbinati, D.
    VALUE IN HEALTH, 2019, 22 : S607 - S607
  • [8] Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US
    William V. Padula
    Sonal Parasrampuria
    Mariana P. Socal
    Rena M. Conti
    Gerard F. Anderson
    PharmacoEconomics, 2020, 38 : 1115 - 1121
  • [9] Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US”
    Richard Manning
    PharmacoEconomics, 2020, 38 : 1373 - 1374
  • [10] Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US
    Padula, William V.
    Parasrampuria, Sonal
    Socal, Mariana P.
    Conti, Rena M.
    Anderson, Gerard F.
    PHARMACOECONOMICS, 2020, 38 (10) : 1115 - 1121
12345